Targeting metalloenzymes for therapeutic intervention

AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …

Iron in the tumor microenvironment—connecting the dots

C Pfeifhofer-Obermair, P Tymoszuk, V Petzer… - Frontiers in …, 2018 - frontiersin.org
Iron metabolism and tumor biology are intimately linked. Iron facilitates the production of
oxygen radicals, which may either result in iron-induced cell death, ferroptosis, or contribute …

Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness

H Lu, Y Xie, L Tran, J Lan, Y Yang… - The Journal of …, 2020 - Am Soc Clin Investig
Breast cancer stem cells (BCSCs) play a critical role in cancer recurrence and metastasis.
Chemotherapy induces BCSC specification through increased expression of pluripotency …

Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature

J Abu-Hanna, JA Patel, E Anastasakis, R Cohen… - Clinical …, 2022 - Springer
Abstract Histone 3 lysine 27 (H3K27) demethylation constitutes an important epigenetic
mechanism of gene activation. It is mediated by the Jumonji C domain-containing lysine …

GSK‐J4: An H3K27 histone demethylase inhibitor, as a potential anti‐cancer agent

N Dalpatraj, A Naik, N Thakur - International Journal of Cancer, 2023 - Wiley Online Library
Aberrant epigenetic modifications are emerging as potent drivers of tumor initiation and
progression. The deregulation of H3K27me3 marks has shown to play an important role in …

xCT inhibitor sulfasalazine depletes paclitaxel‑resistant tumor cells through ferroptosis in uterine serous carcinoma

A Sugiyama, T Ohta, M Obata… - Oncology …, 2020 - spandidos-publications.com
Glutathione (GSH) is a primary antioxidant that protects cells against reactive oxygen
species (ROS), and high levels of GSH promote cancer cell survival and resistance to …

GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells

N Yan, L Xu, X Wu, L Zhang, X Fei, Y Cao… - Experimental cell …, 2017 - Elsevier
Recently, studies have been suggested that H3K27me3 is implicated with maintenance of
cancer stem cells (CSCs), however, the roles of H3K27me3 in Breast cancer stem cells …

Metformin directly targets the H3K27me3 demethylase KDM6A/UTX

E Cuyas, S Verdura, L Llorach‐Pares… - Aging cell, 2018 - Wiley Online Library
Metformin, the first drug chosen to be tested in a clinical trial aimed to target the biology of
aging per se, has been clinically exploited for decades in the absence of a complete …

Targeting glioma stem‐like cell survival and chemoresistance through inhibition of lysine‐specific histone demethylase KDM 2B

M Staberg, RD Rasmussen, SR Michaelsen… - Molecular …, 2018 - Wiley Online Library
Glioblastoma (GBM) ranks among the most lethal cancers, with current therapies offering
only palliation. Inter‐and intrapatient heterogeneity is a hallmark of GBM, with epigenetically …

[HTML][HTML] Lung cancer therapy targeting histone methylation: opportunities and challenges

Y Chen, X Liu, Y Li, C Quan, L Zheng… - Computational and …, 2018 - Elsevier
Lung cancer is one of the most common malignancies. In spite of the progress made in past
decades, further studies to improve current therapy for lung cancer are required …